Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Intro to evaluating ETF tax efficiency, including consideration of ETF structure, distributions, and fund-specific strategies.
25,157 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
As earnings season kicks off, public comments surge over the SEC's bid to allow semiannual reporting. ExxonMobil's CF...
Robinhood launches its on-chain network, sparking a memecoin surge as traders rush into DeFi and tokenized assets. Th...
NVIDIA is at the center of the AI hardware boom, fueling bets that the stock will climb to new highs by 2027. Analyst...
Mega-cap tech now drives most S&P 500 gains, leaving the rest of the market with thinner support. Here’s what investo...
TIAA’s CEO argues that leaders should rent the title, not own it, and invest in character traits that endure beyond a...
Five leading U.S. lenders posted stronger-than-expected quarterly results, challenging fears of a slowing economy and...
Dell's disciplined AI server strategy contrasts with Super Micro's margin challenges, underscoring two big server bet...
Cardano’s Van Rossem hard fork is set to activate tomorrow, amid a surge in whale buying and rising open interest. Tr...
A viral moment at Wrigley Field sparked questions about safety and money. This guide shows smart budgeting, risk chec...
Internal documents reveal OpenAI posted $21B in losses on $13B in revenue, signaling a costly push to scale AI at bre...
A new study shows AI-native startups favor seasoned staff, trimming entry-level roles and altering the career path an...